Tenet Healthcare (NYSE:THC) Updates FY 2025 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 11.740-12.840 for the period, compared to the consensus earnings per share estimate of 11.080. The company issued revenue guidance of $20.6 billion-$21.0 billion, compared to the consensus revenue estimate of $21.3 billion.

Tenet Healthcare Stock Performance

THC stock opened at $135.99 on Friday. The firm has a market cap of $12.93 billion, a P/E ratio of 4.36, a P/E/G ratio of 0.63 and a beta of 2.05. The stock’s 50 day simple moving average is $133.43 and its 200 day simple moving average is $148.26. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. Tenet Healthcare has a 12-month low of $88.57 and a 12-month high of $171.20.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. As a group, equities research analysts predict that Tenet Healthcare will post 11.37 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. StockNews.com cut shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday. KeyCorp cut their price objective on Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. The Goldman Sachs Group lowered shares of Tenet Healthcare from a “buy” rating to a “neutral” rating and cut their price target for the company from $196.00 to $140.00 in a report on Monday, December 16th. Raymond James downgraded Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective for the company. in a research note on Friday, November 22nd. Finally, Royal Bank of Canada increased their target price on shares of Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $163.19.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.